Wang Ke Xin - Net Worth and Insider Trading
Wang Ke Xin Net Worth
The estimated net worth of Wang Ke Xin is at least $10 Million dollars as of 2024-11-13. Wang Ke Xin is the Director of Shanghai Fosun Pharmaceutical (Group) Co Ltd and owns about 376,684 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) stock worth over $10 Million. Details can be seen in Wang Ke Xin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Wang Ke Xin has not made any transactions after 2024-09-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Wang Ke Xin
Wang Ke Xin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Wang Ke Xin owns 1 companies in total, including Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) .
Click here to see the complete history of Wang Ke Xin’s form 4 insider trades.
Insider Ownership Summary of Wang Ke Xin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2024-09-27 | Director |
Wang Ke Xin Latest Holdings Summary
Wang Ke Xin currently owns a total of 1 stock. Wang Ke Xin owns 376,684 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) as of September 27, 2024, with a value of $10 Million.
Latest Holdings of Wang Ke Xin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600196 | Shanghai Fosun Pharmaceutical (Group) Co Ltd | 2024-09-27 | 376,684 | 27.69 | 10,430,380 |
Holding Weightings of Wang Ke Xin
Wang Ke Xin Form 4 Trading Tracker
According to the SEC Form 4 filings, Wang Ke Xin has made a total of 3 transactions in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Shanghai Fosun Pharmaceutical (Group) Co Ltd is the sale of 71,016 shares on September 27, 2024, which brought Wang Ke Xin around $2 Million.
Insider Trading History of Wang Ke Xin
- 1
Wang Ke Xin Trading Performance
GuruFocus tracks the stock performance after each of Wang Ke Xin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Wang Ke Xin is -1.74%. GuruFocus also compares Wang Ke Xin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Wang Ke Xin within 3 months outperforms 0 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Wang Ke Xin's insider trading performs compared to the benchmark.
Performance of Wang Ke Xin
Wang Ke Xin Ownership Network
Ownership Network List of Wang Ke Xin
Ownership Network Relation of Wang Ke Xin
Wang Ke Xin Owned Company Details
What does Shanghai Fosun Pharmaceutical (Group) Co Ltd do?
Who are the key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd?
Wang Ke Xin is the Director of Shanghai Fosun Pharmaceutical (Group) Co Ltd. Other key executives at Shanghai Fosun Pharmaceutical (Group) Co Ltd include Directors & senior managers wen de yong , senior management bao qin gui , and senior management Mei Jing Ping .
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) Insider Trades Summary
Over the past 18 months, Wang Ke Xin made 1 insider transaction in Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) with a net sale of 0. Other recent insider transactions involving Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) include a net sale of 0 shares made by wen de yong , a net sale of 0 shares made by Guan Xiao Hui , and a net sale of 0 shares made by Wu Yi Fang .
In summary, during the past 3 months, insiders sold 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Shanghai Fosun Pharmaceutical (Group) Co Ltd (SHSE:600196)'s detailed insider trading history can be found in Insider Trading Tracker table.
Shanghai Fosun Pharmaceutical (Group) Co Ltd Insider Transactions
Wang Ke Xin Mailing Address
Above is the net worth, insider trading, and ownership report for Wang Ke Xin. Currently GuruFocus does not have mailing address information for Wang Ke Xin.